Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Limelight Networks still trades at 'too great a discount,' says Lake Street » 08:55
06/10/21
06/10
08:55
06/10/21
08:55
LLNW

Limelight Networks

$3.21 /

-0.065 (-1.98%)

After having recently…

After having recently hosted Limelight Networks management for investor meetings, Lake Street analyst Eric Martinuzzi said he thinks the company has repaired relationships with top customers and continues to improve its video streaming CDN service. The analyst, who believes the shares "remain at too great a discount to intrinsic value," keeps a Buy rating and $5.50 price target on Limelight shares.

ShowHide Related Items >><<
LLNW Limelight Networks
$3.21 /

-0.065 (-1.98%)

LLNW Limelight Networks
$3.21 /

-0.065 (-1.98%)

03/19/21 DA Davidson
Limelight Networks price target lowered to $2.75 from $3.00 at DA Davidson
02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
LLNW Limelight Networks
$3.21 /

-0.065 (-1.98%)

LLNW Limelight Networks
$3.21 /

-0.065 (-1.98%)

LLNW Limelight Networks
$3.21 /

-0.065 (-1.98%)

Conference/Events
Limelight Networks management to meet virtually with Lake Street » 04:55
06/09/21
06/09
04:55
06/09/21
04:55
LLNW

Limelight Networks

$3.28 /

+0.09 (+2.83%)

Virtual Meeting to be…

Virtual Meeting to be held on June 9 hosted by Lake Street.

ShowHide Related Items >><<
LLNW Limelight Networks
$3.28 /

+0.09 (+2.83%)

LLNW Limelight Networks
$3.28 /

+0.09 (+2.83%)

03/19/21 DA Davidson
Limelight Networks price target lowered to $2.75 from $3.00 at DA Davidson
02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
LLNW Limelight Networks
$3.28 /

+0.09 (+2.83%)

LLNW Limelight Networks
$3.28 /

+0.09 (+2.83%)

LLNW Limelight Networks
$3.28 /

+0.09 (+2.83%)

Conference/Events
Limelight Networks management to meet virtually with Lake Street » 11:57
06/08/21
06/08
11:57
06/08/21
11:57
LLNW

Limelight Networks

$3.20 /

+0.01 (+0.31%)

Virtual Meeting to be…

Virtual Meeting to be held on June 9 hosted by Lake Street.

ShowHide Related Items >><<
LLNW Limelight Networks
$3.20 /

+0.01 (+0.31%)

LLNW Limelight Networks
$3.20 /

+0.01 (+0.31%)

03/19/21 DA Davidson
Limelight Networks price target lowered to $2.75 from $3.00 at DA Davidson
02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
LLNW Limelight Networks
$3.20 /

+0.01 (+0.31%)

LLNW Limelight Networks
$3.20 /

+0.01 (+0.31%)

LLNW Limelight Networks
$3.20 /

+0.01 (+0.31%)

Over a month ago
Earnings
Limelight Networks sees FY21 non-GAAP EPS (15c)-(5c), consensus (5c) » 16:09
04/29/21
04/29
16:09
04/29/21
16:09
LLNW

Limelight Networks

$3.64 /

+ (+0.00%)

Sees FY21 revenue…

Sees FY21 revenue $220M-$230M, consensus $225.38M.

ShowHide Related Items >><<
LLNW Limelight Networks
$3.64 /

+ (+0.00%)

LLNW Limelight Networks
$3.64 /

+ (+0.00%)

03/19/21 DA Davidson
Limelight Networks price target lowered to $2.75 from $3.00 at DA Davidson
02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
LLNW Limelight Networks
$3.64 /

+ (+0.00%)

LLNW Limelight Networks
$3.64 /

+ (+0.00%)

LLNW Limelight Networks
$3.64 /

+ (+0.00%)

Earnings
Limelight Networks reports Q1 non-GAAP EPS (9c), consensus (3c) » 16:08
04/29/21
04/29
16:08
04/29/21
16:08
LLNW

Limelight Networks

$3.64 /

-0.005 (-0.14%)

Reports Q1 revenue…

Reports Q1 revenue $51.2M, consensus $54.17M. "As anticipated, our Q1 was challenging from a top- and bottom-line perspective. That said, I am confident that we are now on the right path to achieve success," said CEO Bob Lyons. "Our three-pillared strategy of improve the core, expand the core and extend the core is serving as our playbook to transform the company and improve execution, profitability and accelerate growth. We have made measurable progress addressing our short-term headwinds and our broader transformation efforts during the quarter. In just a couple of months we have: simplified our operating mode; improved network performance; meaningfully reduced our operating costs; and demonstrated notable improvements in our client SLA's. Additionally, we continue to be excited about, and are looking forward to discussing the opportunity available to Limelight to address a large unmet market need with our globally scaled edge platform and operational know-how."

ShowHide Related Items >><<
LLNW Limelight Networks
$3.64 /

-0.005 (-0.14%)

LLNW Limelight Networks
$3.64 /

-0.005 (-0.14%)

03/19/21 DA Davidson
Limelight Networks price target lowered to $2.75 from $3.00 at DA Davidson
02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
LLNW Limelight Networks
$3.64 /

-0.005 (-0.14%)

LLNW Limelight Networks
$3.64 /

-0.005 (-0.14%)

LLNW Limelight Networks
$3.64 /

-0.005 (-0.14%)

Over a quarter ago
Recommendations
Limelight Networks price target lowered to $2.75 from $3.00 at DA Davidson » 09:33
03/19/21
03/19
09:33
03/19/21
09:33
LLNW

Limelight Networks

$3.32 /

-0.14 (-4.05%)

DA Davidson analyst Rishi…

DA Davidson analyst Rishi Jaluria lowered the firm's price target on Limelight Networks to $2.75 from $3.00 and keeps an Underperform rating on the shares. The company's workforce reduction announced yesterday drove the stock higher afterhours, though he remains concerned with Limelight's underinvesting and continues to expect its turnaround to be "more painful than expected", the analyst tells investors in a research note.

ShowHide Related Items >><<
LLNW Limelight Networks
$3.32 /

-0.14 (-4.05%)

LLNW Limelight Networks
$3.32 /

-0.14 (-4.05%)

02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
02/12/21 Truist
Limelight Networks downgraded to Hold from Buy at Truist
LLNW Limelight Networks
$3.32 /

-0.14 (-4.05%)

LLNW Limelight Networks
$3.32 /

-0.14 (-4.05%)

LLNW Limelight Networks
$3.32 /

-0.14 (-4.05%)

Hot Stocks
Limelight Networks announces workforce reduction to cut $15M in costs » 16:03
03/18/21
03/18
16:03
03/18/21
16:03
LLNW

Limelight Networks

$3.32 /

-0.135 (-3.91%)

The company states:…

The company states: "Consistent with the approach outlined on February 11, the company is taking the following steps to improve its core CDN business, specifically, client performance and operating efficiency. Limelight has: Implemented a simplified operating model that improves agility and productivity; Prioritized resources on the continuous proactive improvement of client performance; and, Improved organizational productivity that results in an annual cash cost savings of approximately $15 million - including a targeted workforce reduction. The reduction has decreased the company's workforce by approximately 16% and results in a first-quarter pre-tax cash charge of approximately $3 million related to severance, benefits and transition assistance. CEO Bob Lyons says: "This reduction in force, while difficult, is an essential part of the disciplined planning and work we need to accomplish to capture the significant opportunity ahead of us. Our efforts to date give us confidence that we will be able to achieve 2021 adjusted EBITDA between $20 and $30 million. We will provide additional financial guidance in connection with our first quarter earnings release."

ShowHide Related Items >><<
LLNW Limelight Networks
$3.32 /

-0.135 (-3.91%)

LLNW Limelight Networks
$3.32 /

-0.135 (-3.91%)

02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
02/12/21 Truist
Limelight Networks downgraded to Hold from Buy at Truist
LLNW Limelight Networks
$3.32 /

-0.135 (-3.91%)

LLNW Limelight Networks
$3.32 /

-0.135 (-3.91%)

LLNW Limelight Networks
$3.32 /

-0.135 (-3.91%)

On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:15
02/12/21
02/12
16:15
02/12/21
16:15
DIS

Disney

$187.69 /

-3.27 (-1.71%)

, EXPE

Expedia

$146.49 /

-3.13 (-2.09%)

, IIVI

II-VI

$89.82 /

-9.81 (-9.85%)

, COHR

Coherent

$257.89 /

+31.66 (+13.99%)

, LITE

Lumentum

$94.00 /

+1.41 (+1.52%)

, MKSI

MKS Instruments

$167.45 /

+5.23 (+3.22%)

, MRNA

Moderna

$183.60 /

+0.18 (+0.10%)

, PFE

Pfizer

$34.72 /

+0.29 (+0.84%)

, GOOG

Alphabet

$2,104.55 /

+8.99 (+0.43%)

, GOOGL

Alphabet Class A

$2,095.83 /

+6.23 (+0.30%)

, MSFT

Microsoft

$244.99 /

+0.6 (+0.25%)

, QCOM

Qualcomm

$147.98 /

+2.53 (+1.74%)

, NVDA

Nvidia

$598.42 /

-11.89 (-1.95%)

, XERS

Xeris Pharmaceuticals

$6.84 /

+0.22 (+3.32%)

, IMGN

ImmunoGen

$10.51 /

+2.405 (+29.67%)

, HUBS

HubSpot

$501.62 /

+69.38 (+16.05%)

, FOLD

Amicus

$12.56 /

-6.2 (-33.05%)

, LLNW

Limelight Networks

$3.96 /

-0.6 (-13.16%)

, NWL

Newell Brands

$24.19 /

-1.85 (-7.10%)

The major averages closed…

ShowHide Related Items >><<
XERS Xeris Pharmaceuticals
$6.84 /

+0.22 (+3.32%)

QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

PFE Pfizer
$34.72 /

+0.29 (+0.84%)

NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

MKSI MKS Instruments
$167.45 /

+5.23 (+3.22%)

LLNW Limelight Networks
$3.96 /

-0.6 (-13.16%)

LITE Lumentum
$94.00 /

+1.41 (+1.52%)

IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

IIVI II-VI
$89.82 /

-9.81 (-9.85%)

HUBS HubSpot
$501.62 /

+69.38 (+16.05%)

GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

FOLD Amicus
$12.56 /

-6.2 (-33.05%)

EXPE Expedia
$146.49 /

-3.13 (-2.09%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

COHR Coherent
$257.89 /

+31.66 (+13.99%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

02/12/21 Loop Capital
Disney price target raised to $230 from $190 at Loop Capital
02/12/21 Evercore ISI
Disney price target raised to $210 from $200 at Evercore ISI
02/12/21 JPMorgan
Disney price target raised to $220 from $210 at JPMorgan
02/12/21 Credit Suisse
Disney price target raised to $218 from $192 at Credit Suisse
EXPE Expedia
$146.49 /

-3.13 (-2.09%)

02/12/21 Stifel
Expedia price target raised to $140 from $117 at Stifel
02/12/21 Cowen
Expedia price target raised to $150 from $140 at Cowen
02/12/21 Benchmark
Expedia price target raised to $175 from $120 at Benchmark
02/12/21 Barclays
Expedia price target raised to $167 from $140 at Barclays
IIVI II-VI
$89.82 /

-9.81 (-9.85%)

02/12/21 Benchmark
Benchmark maintains Buy rating on II-VI after Coherent bid
02/10/21 DA Davidson
II-VI price target raised to $115 from $60 at DA Davidson
02/10/21 Cowen
II-VI price target raised to $124 from $86 at Cowen
02/10/21 Canaccord
II-VI price target raised to $152 from $86 at Canaccord
COHR Coherent
$257.89 /

+31.66 (+13.99%)

02/11/21 Benchmark
Coherent downgraded to Hold from Buy at Benchmark
02/08/21 Stifel
Coherent bid may force Lumentum to raise offer, says Stifel
02/08/21 Benchmark
Coherent deal with MKS could face regulators' scrutiny, says Benchmark
LITE Lumentum
$94.00 /

+1.41 (+1.52%)

MKSI MKS Instruments
$167.45 /

+5.23 (+3.22%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

02/03/21 Piper Sandler
Moderna's vaccine approved in Singapore, says Piper Sandler
02/01/21
Fly Intel: Top five analyst downgrades
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Oppenheimer
Moderna price target raised to $206 from $178 at Oppenheimer
PFE Pfizer
$34.72 /

+0.29 (+0.84%)

02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
02/03/21 Mizuho
Pfizer price target lowered to $42 from $44 at Mizuho
GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

02/12/21 Citi
Citi boosts Alphabet target but shares no longer a top pick
02/08/21 Stephens
Global Payments merchant business advanced by Google pact, says Stephens
02/03/21 JMP Securities
Alphabet price target raised to $2,400 from $1,700 at JMP Securities
02/03/21 JPMorgan
Alphabet price target raised to $2,390 from $2,050 at JPMorgan
GOOGL Alphabet Class A
$2,095.83 /

+6.23 (+0.30%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

02/08/21 KeyBanc
Viva reinforces Microsoft Office/Teams innovation commitment, says KeyBanc
02/08/21 RBC Capital
Datadog price target raised to $110 from $85 at RBC Capital
02/03/21 Wedbush
Cloud arms race hitting another gear with Amazon CEO move, says Wedbush
02/03/21 Jefferies
Alphabet price target raised to $2,400 from $2,150 at Jefferies
QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

02/10/21 JPMorgan
China mobile shipments data point to 'robust' Apple demand, says JPMorgan
02/08/21 JPMorgan
JPMorgan prefers shares of Qualcomm over Apple
02/04/21
Fly Intel: Top five analyst downgrades
02/04/21
Qualcomm price target raised to $150 from $126 at RBC Capital
NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

02/03/21 New Street
Nvidia upgraded to Neutral from Reduce at New Street
01/26/21 Barclays
Nvidia price target raised to $600 from $550 at Barclays
01/25/21 Citi
Citi moves Marvell up to pick in semiconductor equipment
01/15/21 Truist
Nvidia price target raised to $672 from $643 at Truist
XERS Xeris Pharmaceuticals
$6.84 /

+0.22 (+3.32%)

08/20/20 Mizuho
Mizuho sees no material impact to Xeris following FDA letter about advertising
04/23/20 Mizuho
Xeris Pharmaceuticals price target lowered to $14 from $18 at Mizuho
02/20/20 Mizuho
Xeris Pharmaceuticals price target lowered to $18 from $22 at Mizuho
02/18/20
Fly Intel: Top five analyst initiations
IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
10/05/20 Piper Sandler
Piper says r/r BPDCN revenue opportunity for ImmunoGen's 632 'an open question'
HUBS HubSpot
$501.62 /

+69.38 (+16.05%)

02/12/21 Needham
HubSpot price target raised to $520 from $400 at Needham
02/12/21 Cowen
HubSpot price target raised to $510 from $400 at Cowen
02/12/21 Raymond James
HubSpot upgraded to Strong Buy from Outperform at Raymond James
02/12/21 Truist
HubSpot price target raised to $600 from $455 at Truist
FOLD Amicus
$12.56 /

-6.2 (-33.05%)

02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
02/12/21 Cantor Fitzgerald
Amicus downgraded to Neutral from Overweight at Cantor Fitzgerald
LLNW Limelight Networks
$3.96 /

-0.6 (-13.16%)

02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
02/12/21 Truist
Limelight Networks downgraded to Hold from Buy at Truist
NWL Newell Brands
$24.19 /

-1.85 (-7.10%)

02/04/21 Deutsche Bank
Newell Brands price target raised to $23 from $18 at Deutsche Bank
01/08/21 BofA
Newell Brands upgraded to Buy on shift away from home at BofA
01/08/21 BofA
Newell Brands upgraded to Buy from Neutral at BofA
01/04/21 Jefferies
Jefferies upgrades 'underappreciated' Newell Brands to Buy from Hold
XERS Xeris Pharmaceuticals
$6.84 /

+0.22 (+3.32%)

QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

PFE Pfizer
$34.72 /

+0.29 (+0.84%)

NWL Newell Brands
$24.19 /

-1.85 (-7.10%)

NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

MKSI MKS Instruments
$167.45 /

+5.23 (+3.22%)

LLNW Limelight Networks
$3.96 /

-0.6 (-13.16%)

LITE Lumentum
$94.00 /

+1.41 (+1.52%)

IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

IIVI II-VI
$89.82 /

-9.81 (-9.85%)

HUBS HubSpot
$501.62 /

+69.38 (+16.05%)

GOOGL Alphabet Class A
$2,095.83 /

+6.23 (+0.30%)

GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

FOLD Amicus
$12.56 /

-6.2 (-33.05%)

EXPE Expedia
$146.49 /

-3.13 (-2.09%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

COHR Coherent
$257.89 /

+31.66 (+13.99%)

  • 02
    Jul
  • 26
    Jun
  • 19
    May
QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

PFE Pfizer
$34.72 /

+0.29 (+0.84%)

NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

IIVI II-VI
$89.82 /

-9.81 (-9.85%)

HUBS HubSpot
$501.62 /

+69.38 (+16.05%)

GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

FOLD Amicus
$12.56 /

-6.2 (-33.05%)

EXPE Expedia
$146.49 /

-3.13 (-2.09%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

COHR Coherent
$257.89 /

+31.66 (+13.99%)

XERS Xeris Pharmaceuticals
$6.84 /

+0.22 (+3.32%)

QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

PFE Pfizer
$34.72 /

+0.29 (+0.84%)

NWL Newell Brands
$24.19 /

-1.85 (-7.10%)

NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

LITE Lumentum
$94.00 /

+1.41 (+1.52%)

IMGN ImmunoGen
$10.51 /

+2.405 (+29.67%)

IIVI II-VI
$89.82 /

-9.81 (-9.85%)

GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

FOLD Amicus
$12.56 /

-6.2 (-33.05%)

EXPE Expedia
$146.49 /

-3.13 (-2.09%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

COHR Coherent
$257.89 /

+31.66 (+13.99%)

XERS Xeris Pharmaceuticals
$6.84 /

+0.22 (+3.32%)

QCOM Qualcomm
$147.98 /

+2.53 (+1.74%)

PFE Pfizer
$34.72 /

+0.29 (+0.84%)

NVDA Nvidia
$598.42 /

-11.89 (-1.95%)

MSFT Microsoft
$244.99 /

+0.6 (+0.25%)

MRNA Moderna
$183.60 /

+0.18 (+0.10%)

LLNW Limelight Networks
$3.96 /

-0.6 (-13.16%)

LITE Lumentum
$94.00 /

+1.41 (+1.52%)

GOOGL Alphabet Class A
$2,095.83 /

+6.23 (+0.30%)

GOOG Alphabet
$2,104.55 /

+8.99 (+0.43%)

FOLD Amicus
$12.56 /

-6.2 (-33.05%)

EXPE Expedia
$146.49 /

-3.13 (-2.09%)

DIS Disney
$187.69 /

-3.27 (-1.71%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:09
02/12/21
02/12
12:09
02/12/21
12:09
XERS

Xeris Pharmaceuticals

$7.08 /

+0.46 (+6.95%)

, DIS

Disney

$189.57 /

-1.39 (-0.73%)

, EXPE

Expedia

$146.81 /

-2.81 (-1.88%)

, IIVI

II-VI

$93.24 /

-6.39 (-6.41%)

, COHR

Coherent

$259.58 /

+33.35 (+14.74%)

, LITE

Lumentum

$94.62 /

+2.03 (+2.19%)

, MKSI

MKS Instruments

$167.71 /

+5.49 (+3.38%)

, MRNA

Moderna

$180.40 /

-3.02 (-1.65%)

, PFE

Pfizer

$34.85 /

+0.42 (+1.22%)

, IMGN

ImmunoGen

$10.56 /

+2.455 (+30.29%)

, HUBS

HubSpot

$503.52 /

+71.28 (+16.49%)

, FOLD

Amicus

$12.73 /

-6.03 (-32.14%)

, LLNW

Limelight Networks

$3.58 /

-0.98 (-21.49%)

, NWL

Newell Brands

$24.15 /

-1.89 (-7.26%)

The major averages are…

ShowHide Related Items >><<
XERS Xeris Pharmaceuticals
$7.08 /

+0.46 (+6.95%)

PFE Pfizer
$34.85 /

+0.42 (+1.22%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

MKSI MKS Instruments
$167.71 /

+5.49 (+3.38%)

LLNW Limelight Networks
$3.58 /

-0.98 (-21.49%)

LITE Lumentum
$94.62 /

+2.03 (+2.19%)

IMGN ImmunoGen
$10.56 /

+2.455 (+30.29%)

IIVI II-VI
$93.24 /

-6.39 (-6.41%)

HUBS HubSpot
$503.52 /

+71.28 (+16.49%)

FOLD Amicus
$12.73 /

-6.03 (-32.14%)

EXPE Expedia
$146.81 /

-2.81 (-1.88%)

DIS Disney
$189.57 /

-1.39 (-0.73%)

COHR Coherent
$259.58 /

+33.35 (+14.74%)

XERS Xeris Pharmaceuticals
$7.08 /

+0.46 (+6.95%)

08/20/20 Mizuho
Mizuho sees no material impact to Xeris following FDA letter about advertising
04/23/20 Mizuho
Xeris Pharmaceuticals price target lowered to $14 from $18 at Mizuho
02/20/20 Mizuho
Xeris Pharmaceuticals price target lowered to $18 from $22 at Mizuho
02/18/20
Fly Intel: Top five analyst initiations
DIS Disney
$189.57 /

-1.39 (-0.73%)

02/12/21 Loop Capital
Disney price target raised to $230 from $190 at Loop Capital
02/12/21 Evercore ISI
Disney price target raised to $210 from $200 at Evercore ISI
02/12/21 JPMorgan
Disney price target raised to $220 from $210 at JPMorgan
02/12/21 Credit Suisse
Disney price target raised to $218 from $192 at Credit Suisse
EXPE Expedia
$146.81 /

-2.81 (-1.88%)

02/12/21 Stifel
Expedia price target raised to $140 from $117 at Stifel
02/12/21 Cowen
Expedia price target raised to $150 from $140 at Cowen
02/12/21 Benchmark
Expedia price target raised to $175 from $120 at Benchmark
02/12/21 Barclays
Expedia price target raised to $167 from $140 at Barclays
IIVI II-VI
$93.24 /

-6.39 (-6.41%)

02/12/21 Benchmark
Benchmark maintains Buy rating on II-VI after Coherent bid
02/10/21 DA Davidson
II-VI price target raised to $115 from $60 at DA Davidson
02/10/21 Cowen
II-VI price target raised to $124 from $86 at Cowen
02/10/21 Canaccord
II-VI price target raised to $152 from $86 at Canaccord
COHR Coherent
$259.58 /

+33.35 (+14.74%)

02/11/21 Benchmark
Coherent downgraded to Hold from Buy at Benchmark
02/08/21 Stifel
Coherent bid may force Lumentum to raise offer, says Stifel
02/08/21 Benchmark
Coherent deal with MKS could face regulators' scrutiny, says Benchmark
LITE Lumentum
$94.62 /

+2.03 (+2.19%)

MKSI MKS Instruments
$167.71 /

+5.49 (+3.38%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

02/03/21 Piper Sandler
Moderna's vaccine approved in Singapore, says Piper Sandler
02/01/21
Fly Intel: Top five analyst downgrades
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Oppenheimer
Moderna price target raised to $206 from $178 at Oppenheimer
PFE Pfizer
$34.85 /

+0.42 (+1.22%)

02/10/21 KeyBanc
Maravai Lifesciences price target raised to $39 from $33 at KeyBanc
02/04/21 DZ Bank
Pfizer upgraded to Buy from Hold at DZ Bank
02/03/21 Mizuho
Pfizer price target lowered to $42 from $44 at Mizuho
IMGN ImmunoGen
$10.56 /

+2.455 (+30.29%)

12/07/20 Piper Sandler
ImmunoGen price target raised to $6.50 from $5.50 at Piper Sandler
10/26/20 H.C. Wainwright
ImmunoGen assumed with a Buy at H.C. Wainwright
10/19/20 Piper Sandler
Greater China partnership 'very favorable' for ImmunoGen, says Piper Sandler
10/05/20 Piper Sandler
Piper says r/r BPDCN revenue opportunity for ImmunoGen's 632 'an open question'
HUBS HubSpot
$503.52 /

+71.28 (+16.49%)

02/12/21 Needham
HubSpot price target raised to $520 from $400 at Needham
02/12/21 Cowen
HubSpot price target raised to $510 from $400 at Cowen
02/12/21 Raymond James
HubSpot upgraded to Strong Buy from Outperform at Raymond James
02/12/21 Truist
HubSpot price target raised to $600 from $455 at Truist
FOLD Amicus
$12.73 /

-6.03 (-32.14%)

02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
02/12/21 Cantor Fitzgerald
Amicus downgraded to Neutral from Overweight at Cantor Fitzgerald
LLNW Limelight Networks
$3.58 /

-0.98 (-21.49%)

02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
02/12/21 Truist
Limelight Networks downgraded to Hold from Buy at Truist
NWL Newell Brands
$24.15 /

-1.89 (-7.26%)

02/04/21 Deutsche Bank
Newell Brands price target raised to $23 from $18 at Deutsche Bank
01/08/21 BofA
Newell Brands upgraded to Buy on shift away from home at BofA
01/08/21 BofA
Newell Brands upgraded to Buy from Neutral at BofA
01/04/21 Jefferies
Jefferies upgrades 'underappreciated' Newell Brands to Buy from Hold
XERS Xeris Pharmaceuticals
$7.08 /

+0.46 (+6.95%)

PFE Pfizer
$34.85 /

+0.42 (+1.22%)

NWL Newell Brands
$24.15 /

-1.89 (-7.26%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

MKSI MKS Instruments
$167.71 /

+5.49 (+3.38%)

LLNW Limelight Networks
$3.58 /

-0.98 (-21.49%)

LITE Lumentum
$94.62 /

+2.03 (+2.19%)

IMGN ImmunoGen
$10.56 /

+2.455 (+30.29%)

IIVI II-VI
$93.24 /

-6.39 (-6.41%)

HUBS HubSpot
$503.52 /

+71.28 (+16.49%)

FOLD Amicus
$12.73 /

-6.03 (-32.14%)

EXPE Expedia
$146.81 /

-2.81 (-1.88%)

DIS Disney
$189.57 /

-1.39 (-0.73%)

COHR Coherent
$259.58 /

+33.35 (+14.74%)

  • 02
    Jul
  • 26
    Jun
  • 19
    May
PFE Pfizer
$34.85 /

+0.42 (+1.22%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

IIVI II-VI
$93.24 /

-6.39 (-6.41%)

HUBS HubSpot
$503.52 /

+71.28 (+16.49%)

FOLD Amicus
$12.73 /

-6.03 (-32.14%)

EXPE Expedia
$146.81 /

-2.81 (-1.88%)

DIS Disney
$189.57 /

-1.39 (-0.73%)

COHR Coherent
$259.58 /

+33.35 (+14.74%)

XERS Xeris Pharmaceuticals
$7.08 /

+0.46 (+6.95%)

PFE Pfizer
$34.85 /

+0.42 (+1.22%)

NWL Newell Brands
$24.15 /

-1.89 (-7.26%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

MKSI MKS Instruments
$167.71 /

+5.49 (+3.38%)

LLNW Limelight Networks
$3.58 /

-0.98 (-21.49%)

LITE Lumentum
$94.62 /

+2.03 (+2.19%)

IMGN ImmunoGen
$10.56 /

+2.455 (+30.29%)

IIVI II-VI
$93.24 /

-6.39 (-6.41%)

HUBS HubSpot
$503.52 /

+71.28 (+16.49%)

FOLD Amicus
$12.73 /

-6.03 (-32.14%)

EXPE Expedia
$146.81 /

-2.81 (-1.88%)

DIS Disney
$189.57 /

-1.39 (-0.73%)

COHR Coherent
$259.58 /

+33.35 (+14.74%)

XERS Xeris Pharmaceuticals
$7.08 /

+0.46 (+6.95%)

PFE Pfizer
$34.85 /

+0.42 (+1.22%)

NWL Newell Brands
$24.15 /

-1.89 (-7.26%)

MRNA Moderna
$180.40 /

-3.02 (-1.65%)

LLNW Limelight Networks
$3.58 /

-0.98 (-21.49%)

LITE Lumentum
$94.62 /

+2.03 (+2.19%)

FOLD Amicus
$12.73 /

-6.03 (-32.14%)

EXPE Expedia
$146.81 /

-2.81 (-1.88%)

DIS Disney
$189.57 /

-1.39 (-0.73%)

On The Fly
Initiation of 'disrupter' Inovio among today's top calls on Wall Street » 09:37
02/12/21
02/12
09:37
02/12/21
09:37
INO

Inovio

$13.00 /

+ (+0.00%)

, THS

TreeHouse

$49.39 /

-1.31 (-2.58%)

, LLNW

Limelight Networks

$4.56 /

-0.08 (-1.72%)

, FSR

Fisker

$15.42 /

-0.2 (-1.28%)

, RIDE

Lordstown Motors

$30.71 /

+1.21 (+4.10%)

, GOOG

Alphabet

$2,096.87 /

+2.5 (+0.12%)

, GOOGL

Alphabet Class A

$2,088.06 /

+0.76 (+0.04%)

Check out today's top…

ShowHide Related Items >><<
THS TreeHouse
$49.39 /

-1.31 (-2.58%)

RIDE Lordstown Motors
$30.71 /

+1.21 (+4.10%)

LLNW Limelight Networks
$4.56 /

-0.08 (-1.72%)

INO Inovio
$13.00 /

+ (+0.00%)

GOOG Alphabet
$2,096.87 /

+2.5 (+0.12%)

FSR Fisker
$15.42 /

-0.2 (-1.28%)

INO Inovio
$13.00 /

+ (+0.00%)

02/11/21 Oppenheimer
Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
02/11/21 Oppenheimer
Inovio initiated with an Outperform at Oppenheimer
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
01/08/21 Benchmark
Inovio price target lowered to $15 from $25 at Benchmark
THS TreeHouse
$49.39 /

-1.31 (-2.58%)

02/12/21 Truist
TreeHouse downgraded to Hold from Buy at Truist
02/12/21 Truist
TreeHouse downgraded to Hold from Buy at Truist
02/12/21 BofA
TreeHouse downgraded to Neutral from Buy at BofA
02/12/21 BofA
TreeHouse downgraded to Neutral from Buy at BofA
LLNW Limelight Networks
$4.56 /

-0.08 (-1.72%)

02/12/21 Lake Street
Limelight Networks price target lowered to $6 from $9 at Lake Street
02/12/21 DA Davidson
Limelight Networks downgraded to Underperform from Neutral at DA Davidson
02/12/21 Raymond James
Limelight Networks downgraded to Market Perform from Outperform at Raymond James
02/12/21 Truist
Limelight Networks downgraded to Hold from Buy at Truist
FSR Fisker
$15.42 /

-0.2 (-1.28%)

02/11/21 Morgan Stanley
Fisker initiated with an Overweight at Morgan Stanley
01/21/21 Raymond James
Raymond James starts Fisker with Market Perform given 'crowded space'
01/21/21 Raymond James
Fisker initiated with a Market Perform at Raymond James
01/04/21
Fly Intel: Top five analyst initiations
RIDE Lordstown Motors
$30.71 /

+1.21 (+4.10%)

02/11/21 Morgan Stanley
Lordstown Motors initiated with an Underweight at Morgan Stanley
01/29/21 Wolfe Research
Wolfe upgrades Lordstown Motors to Peer Perform, says 'narrative has changed'
01/29/21 Wolfe Research
Lordstown Motors upgraded to Peer Perform from Underperform at Wolfe Research
12/22/20 R.F. Lafferty
Lordstown Motors initiated with a Buy at R.F. Lafferty
GOOG Alphabet
$2,096.87 /

+2.5 (+0.12%)

02/12/21 Citi
Citi boosts Alphabet target but shares no longer a top pick
02/08/21 Stephens
Global Payments merchant business advanced by Google pact, says Stephens
02/03/21 JMP Securities
Alphabet price target raised to $2,400 from $1,700 at JMP Securities
02/03/21 JPMorgan
Alphabet price target raised to $2,390 from $2,050 at JPMorgan
GOOGL Alphabet Class A
$2,088.06 /

+0.76 (+0.04%)

THS TreeHouse
$49.39 /

-1.31 (-2.58%)

LLNW Limelight Networks
$4.56 /

-0.08 (-1.72%)

INO Inovio
$13.00 /

+ (+0.00%)

GOOGL Alphabet Class A
$2,088.06 /

+0.76 (+0.04%)

GOOG Alphabet
$2,096.87 /

+2.5 (+0.12%)

  • 21
    Jan
THS TreeHouse
$49.39 /

-1.31 (-2.58%)

RIDE Lordstown Motors
$30.71 /

+1.21 (+4.10%)

INO Inovio
$13.00 /

+ (+0.00%)

GOOG Alphabet
$2,096.87 /

+2.5 (+0.12%)

FSR Fisker
$15.42 /

-0.2 (-1.28%)

RIDE Lordstown Motors
$30.71 /

+1.21 (+4.10%)

LLNW Limelight Networks
$4.56 /

-0.08 (-1.72%)

INO Inovio
$13.00 /

+ (+0.00%)

GOOG Alphabet
$2,096.87 /

+2.5 (+0.12%)

FSR Fisker
$15.42 /

-0.2 (-1.28%)

RIDE Lordstown Motors
$30.71 /

+1.21 (+4.10%)

LLNW Limelight Networks
$4.56 /

-0.08 (-1.72%)

INO Inovio
$13.00 /

+ (+0.00%)

GOOGL Alphabet Class A
$2,088.06 /

+0.76 (+0.04%)

GOOG Alphabet
$2,096.87 /

+2.5 (+0.12%)

FSR Fisker
$15.42 /

-0.2 (-1.28%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.